The objective of the Zoster Eye Disease Study (ZEDS) is to determine whether prolonged suppressive oral antiviral treatment with valacyclovir reduces complications of Herpes Zoster Ophthalmicus (HZO), thereby improving clinical outcomes in this common and potentially vision- and life-threatening disease.
|Effective start/end date||10/24/19 → 7/31/23|
- New York University, School of Medicine (PCC 115 Mod 1 FE)
- National Eye Institute (PCC 115 Mod 1 FE)
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.